Free Trial

Trinity Financial Advisors LLC Buys 234,500 Shares of P3 Health Partners Inc. $PIII

P3 Health Partners logo with Medical background

Key Points

  • Trinity Financial Advisors LLC increased its stake in P3 Health Partners Inc. by 22.5%, acquiring an additional 234,500 shares to hold a total of 1,278,037 shares, representing approximately 17.80% of the company.
  • P3 Health Partners reported an EPS of ($6.23), significantly missing analysts' expectations, with a revenue of $355.79 million for the quarter compared to a forecast of $356.52 million.
  • Analyst ratings for P3 Health Partners currently show a consensus rating of "Moderate Buy", with a target price of $16.25 following coverage initiation by Lake Street Capital.
  • Five stocks to consider instead of P3 Health Partners.

Trinity Financial Advisors LLC boosted its holdings in P3 Health Partners Inc. (NASDAQ:PIII - Free Report) by 22.5% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,278,037 shares of the company's stock after purchasing an additional 234,500 shares during the period. Trinity Financial Advisors LLC owned about 17.80% of P3 Health Partners worth $222,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in PIII. Wealthedge Investment Advisors LLC purchased a new position in shares of P3 Health Partners during the 4th quarter valued at $83,000. Abundance Wealth Counselors lifted its position in shares of P3 Health Partners by 77.3% during the 1st quarter. Abundance Wealth Counselors now owns 400,000 shares of the company's stock valued at $66,000 after buying an additional 174,395 shares during the last quarter. Finally, Cresset Asset Management LLC lifted its position in shares of P3 Health Partners by 33.3% during the 1st quarter. Cresset Asset Management LLC now owns 200,000 shares of the company's stock valued at $33,000 after buying an additional 50,000 shares during the last quarter. Hedge funds and other institutional investors own 7.75% of the company's stock.

P3 Health Partners Stock Performance

Shares of NASDAQ:PIII traded down $0.07 during midday trading on Friday, reaching $8.60. 1,771 shares of the company traded hands, compared to its average volume of 7,174. The company has a quick ratio of 0.31, a current ratio of 0.31 and a debt-to-equity ratio of 2.29. P3 Health Partners Inc. has a 12 month low of $5.80 and a 12 month high of $26.99. The firm has a market capitalization of $61.83 million, a price-to-earnings ratio of -0.19 and a beta of 0.82. The firm's fifty day moving average price is $7.30 and its two-hundred day moving average price is $7.79.

P3 Health Partners (NASDAQ:PIII - Get Free Report) last released its quarterly earnings data on Thursday, August 14th. The company reported ($6.23) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($3.29) by ($2.94). P3 Health Partners had a negative net margin of 9.99% and a negative return on equity of 183.60%. The company had revenue of $355.79 million for the quarter, compared to the consensus estimate of $356.52 million. P3 Health Partners has set its FY 2025 guidance at EPS. On average, equities analysts expect that P3 Health Partners Inc. will post -0.67 earnings per share for the current year.

Wall Street Analyst Weigh In

Separately, Lake Street Capital initiated coverage on P3 Health Partners in a research report on Thursday, August 28th. They set a "buy" rating and a $20.00 price target on the stock. One analyst has rated the stock with a Buy rating and one has given a Hold rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $16.25.

Read Our Latest Research Report on PIII

About P3 Health Partners

(Free Report)

P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.

Featured Articles

Institutional Ownership by Quarter for P3 Health Partners (NASDAQ:PIII)

Should You Invest $1,000 in P3 Health Partners Right Now?

Before you consider P3 Health Partners, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and P3 Health Partners wasn't on the list.

While P3 Health Partners currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.